If you have any question, please feel free to email us. We will touch with you as soon as possible.
Twymeeg tablets 500 mg for type 2 diabetes Imeglimin hydrochloride. Imeglimin Hydrochloride Tablets is an oral anti-diabetic medication. It was approved for use in Japan in June 2021. It is an oxidative phosphorylation blocker that acts to inhibit hepatic gluconeogenesis, increase muscle glucose uptake, and restore normal insulin secretion.
* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.
| Generic name | Imeglimin Hydrochloride Tablets |
| Trade name | Twymeeg |
| Specification | 500mg |
| Main ingredients | Imeglimin Hydrochloride |
| Dosage Form | Tablets |
| MA Holder | 日本住友制药株式会社 |
| Category | Reference Listed Drugs (RLDs) |
Indications:
Twymeeg tablets 500 mg for type 2 diabetes Imeglimin hydrochloride. Imeglimin Hydrochloride Tablets is an oral anti-diabetic medication. It was approved for use in Japan in June 2021. It is an oxidative phosphorylation blocker that acts to inhibit hepatic gluconeogenesis, increase muscle glucose uptake, and restore normal insulin secretion.
For more details, pls contact Janney:
Email: tosun-global@upharm.cn
Wechat/Whatsapp:(+86)18922120575
Hot Tags: imeglimin hydrochloride tablets reference listed drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Olanzapine Tablets, Agomelatine Tablets, Esomeprazole Magnesium Enteric Coated Capsules, Reference Listed Drugs, Argatroban Injection, Bimatoprost Ophthalmic
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
